300 related articles for article (PubMed ID: 15194590)
1. MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis.
Tchetverikov I; Ronday HK; Van El B; Kiers GH; Verzijl N; TeKoppele JM; Huizinga TW; DeGroot J; Hanemaaijer R
Ann Rheum Dis; 2004 Jul; 63(7):881-3. PubMed ID: 15194590
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases in mild and severe temporomandibular joint internal derangement synovial fluid.
Srinivas R; Sorsa T; Tjäderhane L; Niemi E; Raustia A; Pernu H; Teronen O; Salo T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):517-25. PubMed ID: 11346728
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
Ahrens D; Koch AE; Pope RM; Stein-Picarella M; Niedbala MJ
Arthritis Rheum; 1996 Sep; 39(9):1576-87. PubMed ID: 8814070
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis.
Yoshihara Y; Nakamura H; Obata K; Yamada H; Hayakawa T; Fujikawa K; Okada Y
Ann Rheum Dis; 2000 Jun; 59(6):455-61. PubMed ID: 10834863
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase protein expression profiles cannot distinguish between normal and early osteoarthritic synovial fluid.
Heard BJ; Martin L; Rattner JB; Frank CB; Hart DA; Krawetz R
BMC Musculoskelet Disord; 2012 Jul; 13():126. PubMed ID: 22824140
[TBL] [Abstract][Full Text] [Related]
8. MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis.
Tchetverikov I; Lohmander LS; Verzijl N; Huizinga TW; TeKoppele JM; Hanemaaijer R; DeGroot J
Ann Rheum Dis; 2005 May; 64(5):694-8. PubMed ID: 15834054
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
[TBL] [Abstract][Full Text] [Related]
10. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
Vandooren B; Kruithof E; Yu DT; Rihl M; Gu J; De Rycke L; Van Den Bosch F; Veys EM; De Keyser F; Baeten D
Arthritis Rheum; 2004 Sep; 50(9):2942-53. PubMed ID: 15457463
[TBL] [Abstract][Full Text] [Related]
11. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS
Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605
[TBL] [Abstract][Full Text] [Related]
12. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis.
Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik B; Skowronski J; Chwiecko J
Rheumatology (Oxford); 2002 Jan; 41(1):78-87. PubMed ID: 11792884
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints.
Takei I; Takagi M; Santavirta S; Ida H; Hamasaki M; Ishii M; Fukushima S; Ogino T; Konttinen YT
J Biomed Mater Res; 1999 Jun; 45(3):175-83. PubMed ID: 10397973
[TBL] [Abstract][Full Text] [Related]
14. Is pro-matrix metalloproteinase-3 a marker for posttraumatic cartilage degradation?
Bobacz K; Maier R; Fialka C; Ekhart H; Woloszczuk W; Geyer G; Erlacher L; Smolen J; Graninger WB
Osteoarthritis Cartilage; 2003 Sep; 11(9):665-72. PubMed ID: 12954237
[TBL] [Abstract][Full Text] [Related]
15. Determination of interstitial collagenase (MMP-1) in patients with rheumatoid arthritis.
Maeda S; Sawai T; Uzuki M; Takahashi Y; Omoto H; Seki M; Sakurai M
Ann Rheum Dis; 1995 Dec; 54(12):970-5. PubMed ID: 8546529
[TBL] [Abstract][Full Text] [Related]
16. Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study.
Peake NJ; Khawaja K; Myers A; Jones D; Cawston TE; Rowan AD; Foster HE
Rheumatology (Oxford); 2005 Nov; 44(11):1383-9. PubMed ID: 16049050
[TBL] [Abstract][Full Text] [Related]
17. [Dynamics of matrix metalloproteinase (MMP)-13 in the patients with rheumatoid arthritis].
Itoh T; Uzuki M; Shimamura T; Sawai T
Ryumachi; 2002 Feb; 42(1):60-9. PubMed ID: 11925908
[TBL] [Abstract][Full Text] [Related]
18. Implication of MMP-9 and urokinase plasminogen activator (uPA) in the activation of pro-matrix metalloproteinase (MMP)-13.
Kim KS; Lee YA; Choi HM; Yoo MC; Yang HI
Rheumatol Int; 2012 Oct; 32(10):3069-75. PubMed ID: 21913037
[TBL] [Abstract][Full Text] [Related]
19. Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis.
Ishiguro N; Ito T; Obata K; Fujimoto N; Iwata H
J Rheumatol; 1996 Sep; 23(9):1599-604. PubMed ID: 8877931
[TBL] [Abstract][Full Text] [Related]
20. Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis.
Blaser J; Triebel S; Maasjosthusmann U; Romisch J; Krahl-Mateblowski U; Freudenberg W; Fricke R; Tschesche H
Clin Chim Acta; 1996 Jan; 244(1):17-33. PubMed ID: 8919199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
